Target intelligence / Profile preview

Vaginal epithelial barrier

Molecular classification
Other
01

Overview

The vaginal epithelial barrier refers to the physical and functional barrier formed by the stratified squamous epithelium lining the vagina, which plays a crucial role in protecting the female genital tract from pathogens and maintaining reproductive health[1][2][3][4][5][6][7]. The vaginal epithelial barrier is formed by non-keratinized, stratified squamous epithelial cells that constitute multiple layers: basal, parabasal, intermediate, and superficial cells[2][4]. These cells accumulate glycogen under estrogenic stimulation, which supports a healthy Lactobacillus-dominated microbiome, contributing to acidic pH and optimal vaginal health[1][3][4]. The barrier employs cellular junctions—such as tight junctions (E-cadherin, claudins, occludins, JAMs)—to restrict pathogen entry, and is further reinforced by secreted mucins (glycocalyx), antimicrobial peptides, and active immune cell migration (leukocytes)[1][5][7]. The unique permeability of this barrier not only allows for immunological defense but also makes it a focus for mucosal drug delivery research[2]. Disruption of epithelial integrity, through hormonal changes, microbiome imbalance, or direct injury, is associated with elevated risk of infection, inflammation, and reproductive tract disease[3][6][7]. The vaginal maturation index, a cytologic marker, is used clinically to assess epithelial health and hormone sensitivity[4]. The term “vaginal epithelial barrier” describes a tissue/functional barrier rather than a discrete molecular target, receptor, enzyme, transporter, or gene product. Although research focuses on proteins within the barrier, such as tight junction molecules, these should be listed as separate canonical targets (e.g., JAM-A, claudin-1) if specific molecular targets are needed. As a result, “Vaginal epithelial barrier” is not considered a canonical therapeutic target and the query is technically incorrect if seeking a molecule/receptor.

Other names
Vaginal epitheliumCervicovaginal epithelial barrierVaginal mucosal barrier
02

Biological functions

Physical barrier against pathogensImmune regulation (immunosurveillance, synthesis of antimicrobial peptides and immunoglobulins)Regulation of vaginal microbiota (supports Lactobacillus dominance via glycogen)Hormone responsiveness (primarily estrogen-sensitive)Drug delivery permeability
03

Disease associations

Infection (particularly sexually transmitted infections including HIV, Chlamydia, Gonorrhea)InflammationOther (role in vaginal health, dysbiosis, reproductive disorder)
04

Safety considerations

Increased permeability predisposes to STI and infection when disruptedHormonal imbalances (e.g., low estrogen) thin barrier and increase vulnerability to pathogensImpact of microbiome dysbiosis (e.g., bacterial vaginosis)
05

Biomarkers

Vaginal maturation index (VMI, a cytologic marker for estrogen responsiveness and epithelial health)Expression of structural/adhesion proteins: E-cadherin, tight junction proteins (JAM-A, JAM3, occludin, claudin-1, ZO-1)Levels of antimicrobial peptides (beta-defensin, cathelicidin)

Beyond the preview

Go deeper on Vaginal epithelial barrier.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vaginal epithelial barrier.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call